| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.06.24 | ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer | 211 | GlobeNewswire (Europe) | Evorpacept in combination with PADCEV®, an approved antibody-drug conjugate ("ADC"), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with... ► Artikel lesen | |
| 02.06.24 | Nanobiotix S.A.: Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy | 300 | GlobeNewswire (Europe) | Data show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; "ITT") who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later... ► Artikel lesen | |
| 02.06.24 | Celldex Therapeutics, Inc.: Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024 | 172 | GlobeNewswire (Europe) | - Clinically meaningful and statistically significant improvements across multiple angioedema measurements and barzolvolimab dose groups -- Sustained activity with rapid onset within 2 weeks -- Data... ► Artikel lesen | |
| 02.06.24 | NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Enterprise Software Support for NVIDIA IGX With Holoscan | 672 | GlobeNewswire (Europe) | TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- To address the increasing need for real-time AI computing at the industrial edge, NVIDIA today announced the general software availability... ► Artikel lesen | |
| 02.06.24 | NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs | 150 | GlobeNewswire (Europe) | TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced new NVIDIA RTX technology to power AI assistants and digital humans running on new GeForce RTX AI laptops. NVIDIA... ► Artikel lesen | |
| 02.06.24 | NVIDIA Supercharges Ethernet Networking for Generative AI | 356 | GlobeNewswire (Europe) | TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced widespread adoption of the NVIDIA Spectrum-X Ethernet networking platform as well as an accelerated product release... ► Artikel lesen | |
| 02.06.24 | NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World's Millions of Developers Into Generative AI Developers | 207 | GlobeNewswire (Europe) | 150+ Partners Across Every Layer of AI Ecosystem Embedding NIM Inference Microservices to Speed Enterprise AI Application Deployments From Weeks to MinutesNVIDIA Developer Program Members Gain Free... ► Artikel lesen | |
| 02.06.24 | NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars | 230 | GlobeNewswire (Europe) | TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced the general availability of NVIDIA ACE generative AI microservices to accelerate the next wave of digital humans... ► Artikel lesen | |
| 02.06.24 | Intellia Therapeutics, Inc.: Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE) | 339 | GlobeNewswire (Europe) | Extended follow-up data reaching over two years in the earliest patients dosed reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Eight... ► Artikel lesen | |
| 02.06.24 | BioCryst Pharmaceuticals, Inc.: BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO (berotralstat) Treatment | 219 | GlobeNewswire (Europe) | RESEARCH TRIANGLE PARK, N.C., June 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence showing that patients with hereditary angioedema... ► Artikel lesen | |
| 02.06.24 | Bio-Thera Solutions, Ltd: Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | 82 | PR Newswire | GUANGZHOU, China, June 2, 2024 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars,... ► Artikel lesen | |
| 02.06.24 | Dizal Pharmaceutical: Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations | 78 | PR Newswire | The global pivotal WU-KONG1B study investigating sunvozertinib achieved its primary objective with a manageable safety profile in relapsed or refractory NSCLC with EGFR exon20ins.
An ongoing randomized... ► Artikel lesen | |
| 02.06.24 | Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO | 253 | PR Newswire | BEIJING and SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C... ► Artikel lesen | |
| 02.06.24 | Innovent Biologics: Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting | 168 | PR Newswire | SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and... ► Artikel lesen | |
| 02.06.24 | Innovent Biologics: Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2a Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting | 155 | PR Newswire | SAN FRANCISCO, U.S. and SUZHOU, China, June 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and... ► Artikel lesen | |
| 02.06.24 | Stronger Than Ever: Adani Portfolio Delivers Record Performance | 345 | Business Wire | AHMEDABAD, India--(BUSINESS WIRE)--In line with their commitment to upholding the highest standards of transparency, below is the Adani Portfolio's Credit and Result compendium for financial year... ► Artikel lesen | |
| 02.06.24 | Genmab A/S: Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma | 810 | Business Wire | Preliminary analysis of data from the EPCORE NHL-2 study demonstrates patients with previously untreated follicular lymphoma (FL) who received epcoritamab in combination with rituximab-lenalidomide... ► Artikel lesen | |
| 02.06.24 | European Academy of Allergy and Clinical Immunology: Auftakt zum EAACI-Kongress in Valencia, Spanien | 685 | GlobeNewswire (Deutschland) | Schwerpunktthemen sind Präzisionsmedizin, Immuntherapie und Künstliche Intelligenz (KI)
VALENCIA, Spanien, June 02, 2024 (GLOBE NEWSWIRE) -- Der internationale EAACI-Kongress beginnt mit dem Motto... ► Artikel lesen | |
| 02.06.24 | European Academy of Allergy and Clinical Immunology: Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year | 526 | GlobeNewswire (Europe) | The HEAD registry, with nearly 800 patients, serves to evaluate the economic and social impact of allergies at a European level
VALENCIA, Spain, June 02, 2024 (GLOBE NEWSWIRE) -- Allergic diseases... ► Artikel lesen | |
| 02.06.24 | Rad-Schreibtisch fürs Homeoffice: Dein Computer läuft nur, wenn du in die Pedale trittst | 778 | t3n | Der US-amerikanische Tüftler Jim Gregory hat einen Heimtrainer mit integriertem Schreibtisch entwickelt, der Geräte wie Computer, WLAN-Modem oder Drucker mit Strom versorgt. Freilich nur, wenn man kräftig... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 3.909 |
| TESLA | 3.094 |
| STEYR MOTORS | 2.788 |
| DEUTZ | 2.701 |
| RENK GROUP | 2.674 |
| THYSSENKRUPP | 2.608 |
| TUI | 2.277 |
| NEL | 2.175 |
| BYD | 2.126 |
| RHEINMETALL | 2.112 |
| BAYER | 1.516 |
| XIAOMI | 1.456 |
| NOVO NORDISK | 1.371 |
| EVOTEC | 1.302 |
| COMMERZBANK | 1.167 |
| DEUTSCHE BANK | 1.149 |
| BASF | 1.028 |
| VOLKSWAGEN | 996 |
| MERCEDES-BENZ | 973 |
| AIXTRON SE | 970 |
| MUTARES | 958 |
| PUMA | 938 |
| PORSCHE AG | 914 |
| SUPER MICRO COMPUTER | 847 |
| HENSOLDT | 835 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
